Cardiff Oncology (CRDF) Assets (2011 - 2026)

Cardiff Oncology has reported Assets for 15 years, with the latest figure at $61.9 million in Q4 2025.

• Quarterly Assets fell 36.33% year-over-year to $61.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $61.9 million (down 36.33% YoY) and the FY2025 annual result came in at $61.9 million, down 36.33% from the prior year.
• Assets eased to $61.9 million in Q4 2025 per CRDF's latest filing, from $63.8 million in the prior quarter.
• Over five years, Assets peaked at $149.5 million in Q4 2021 and troughed at $61.9 million in Q4 2025.
• A 5-year average of $101.7 million and a median of $97.3 million in 2023 frame the typical range for Assets.
• The sharpest annual moves came in 2021 and 2025: Assets surged 996.64% in 2021, then plunged 36.33% in 2025.
• Over 5 years, Assets stood at $149.5 million in 2021, then decreased by 22.3% to $116.2 million in 2022, then decreased by 29.74% to $81.6 million in 2023, then increased by 19.05% to $97.2 million in 2024, then slumped by 36.33% to $61.9 million in 2025.
• According to Business Quant data, Assets over the past three periods registered $61.9 million, $63.8 million, and $75.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.